Fulgent Genetics, Inc (FLGT)

Etorro trading 970x250
Fulgent Genetics, Inc (FLGT) Logo

About Fulgent Genetics, Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves insurance, hospitals, and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has collaboration with PWNHealth to provide at-home COVID-19 test capabilities. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. Address: 4978 Santa Anita Avenue, Temple City, CA, United States, 91780

Fulgent Genetics, Inc News and around…

Latest news about Fulgent Genetics, Inc (FLGT) common stock and company :

Crossmark Global Holdings, Inc. Buys Cigna Corp, Honda Motor Co, Crown Castle International ...
10 Jan, 2022 Yahoo! Finance

Investment company Crossmark Global Holdings, Inc. (Current Portfolio) buys Cigna Corp, Honda Motor Co, Crown Castle International Corp, Telefonaktiebolaget L M Ericsson, Procter & Gamble Co, sells Eli Lilly and Co, Bank of America Corp, RELX PLC, Kirkland Lake Gold, Motorola Solutions Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Crossmark Global Holdings, Inc..

Implied SLY Analyst Target Price: $117
10 Jan, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— S&P 600 Small Cap ETF (SLY), we found that the implied analyst target price for the ETF based upon its underlying holdings is $116.53 per unit.

Why Shares of Fulgent Genetics Nearly Doubled in 2021
10 Jan, 2022 FinancialContent

It might be a surprise to some shareholders that the company had a great year.

Notable Tuesday Option Activity: FLGT, PRCH, PFE
04 Jan, 2022 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Fulgent Genetics Inc (FLGT), where a total of 3,105 contracts have traded so far, representing approximately 310,500 underlying shares. That amounts to about 66.4% of FLGT's average daily trading volume over the past month of 467,770 shares..

FLGT Crosses Below Key Moving Average Level
04 Jan, 2022 FinancialContent

In trading on Tuesday, shares of Fulgent Genetics Inc (FLGT) crossed below their 200 day moving average of $86.87, changing hands as low as $83.65 per share. Fulgent Genetics Inc shares are currently trading off about 12.8% on the day..

4 Profitable Stocks to Boost Returns Using Net Income Ratio
04 Jan, 2022 Yahoo! Finance

FLGT, LGO, CTRN, and TGH have been selected as the top picks with a high net income ratio.

3 COVID Stocks That Could Double in 2022
04 Jan, 2022 FinancialContent

Want a two-bagger this year? These three COVID stocks just might do it.

10 Health Care Stocks Whale Activity In Today's Session
03 Jan, 2022 FinancialContent

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we ...

2 Cheap Growth Stocks to Buy for 2022
01 Jan, 2022 FinancialContent

These stocks are both trading at less than 15 times their earnings.

Buy These 3 Stocks With Momentum Anomaly for Higher Returns
29 Dec, 2021 Yahoo! Finance

Avis Budget Group (CAR), Signet Jewelers (SIG) and Fulgent Genetics (FLGT) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.

My 2 Favorite Healthcare Stocks for 2022
29 Dec, 2021 FinancialContent

The pandemic may have brought these companies to prominence, but there's much more to the story.

New Strong Buy Stocks for December 28th
28 Dec, 2021 Yahoo! Finance

AAWW, BERY, CAL, FLGT, and MUSA have been added to the Zacks Rank #1 (Strong Buy) List on December 28th.

Big Money Discovers Fulgent Genetics
28 Dec, 2021 Yahoo! Finance

Fulgent Genetics, Inc. (FLGT) stock has soared in 2021, rising +92.3%. And the COVID-19 test maker and genetic services provider could rise even more due to huge demand. But another likely reason is Big Money lifting the stock.

Corona Doom 3.0: Omicron Surge. Profiting From The Boom In COVID-19 Testing Due To The Omicron Wave
22 Dec, 2021 FinancialContent

COVID testing in a parking garage in Miami on Tuesday (photo via Jordan Levin). Good Luck Getting Into A Medical Clinic A ...

Corona Doom 3.0: Omicron Surge
22 Dec, 2021 FinancialContent

One of the beneficiaries of the COVID testing boom is Fulgent Genetics, Inc.

Best Momentum Stocks to Buy for December 21st
21 Dec, 2021 Yahoo! Finance

AMTB, BBW, FLGT, and BLDR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 21, 2021.

5 Value Stocks In The Healthcare Sector
20 Dec, 2021 FinancialContent

What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. ...

Noteworthy Friday Option Activity: FLGT, STNG, F
17 Dec, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Fulgent Genetics Inc (FLGT), where a total volume of 2,449 contracts has been traded thus far today, a contract volume which is representative of approximately 244,900 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 49.7% of FLGT's average daily trading volume over the past month, of 493,030 shares..

We Think Fulgent Genetics (NASDAQ:FLGT) Can Manage Its Debt With Ease
16 Dec, 2021 Yahoo! Finance

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Fulgent Genetics Breaks Above 200-Day Moving Average - Bullish for FLGT
13 Dec, 2021 FinancialContent

In trading on Monday, shares of Fulgent Genetics Inc (FLGT) crossed above their 200 day moving average of $87.21, changing hands as high as $87.53 per share. Fulgent Genetics Inc shares are currently trading up about 1.9% on the day..

Analysts Predict 15% Upside For AFSM
09 Dec, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Active Factor Small Cap ETF (AFSM), we found that the implied analyst target price for the ETF based upon its underlying holdings is $31.63 per unit.

Best Momentum Stocks to Buy for December 8th
08 Dec, 2021 Yahoo! Finance

ACLS, FLGT, GHLD, and BERY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 8, 2021.

New Strong Buy Stocks for December 8th
08 Dec, 2021 Yahoo! Finance

ACLS, BERY, CTRN, FLGT, and GMS have been added to the Zacks Rank #1 (Strong Buy) List on December 8, 2021

Is Fulgent Genetics a Good Healthcare Stock to Buy?
08 Dec, 2021 FinancialContent

Shares fell earlier in the November, but popped again after a robust third-quarter earnings report.

HelioLiver™, an Innovative Liquid Biopsy Test for the Early Detection of Liver Cancer, is Now Commercially Available
06 Dec, 2021 FinancialContent

Helio Health (“Helio”) and its commercial partner, Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), today announced the commercial launch of HelioLiver™, a multi-analyte blood test that incorporates cell free DNA (cfDNA) methylation patterns and serum protein markers for the detection of hepatocellular carcinoma (HCC) – the most common form of liver cancer. HelioLiver can detect HCC at its earliest stages when lesions are still very small, an area where traditional standard-of-care imaging tools often fall short, with the potential to enable more curative treatment options known to increase five-year survival rates by up to 13 times compared to when cancer has metastasized.1,2

How Wide Is Fulgent Genetics' Moat?
03 Dec, 2021 FinancialContent

The genetic testing company's moat is expanding.

3 Stocks That Could Make You Richer in December (and Beyond)
02 Dec, 2021 FinancialContent

Shares of these companies are gift-wrapped for those with patience.

New Strong Buy Stocks for December 2nd
02 Dec, 2021 Yahoo! Finance

GOLF, FLGT, GNK, CDEV, and ATCO have been added to the Zacks Rank #1 (Strong Buy) List on December 2nd.

The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
02 Dec, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy ...

Jim Cramer Weighs In On Carnival, Canadian Pacific Railway And More
02 Dec, 2021 FinancialContent

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Fulgent Genetics, Inc. (NASDAQ: FLGT) is a "mystery" ...

Fulgent Genetics, Inc (FLGT) is a NASDAQ Common Stock listed in , ,

970x250